Bioequivalence Study of Tiotropium 18 μg Inhalation Powder, Hard Capsule With Spiriva®Handihaler® 18 μg Inhalation Powder, Hard Capsule in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Condition:   COPD Interventions:   Combination Product: Test Product - Tiotropium Bromide Inhalation Powder 18 mcg;   Combination Product: Spiriva Handihaler (Tiotropium Bromide) 18 mcg;   Combination Product: Placebo Sponsors:   Xiromed LLC;   Exeltis Healthcare S.L;   Laboratorios Liconsa SA Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials